Spanje - Spaans - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis belgium sa - virus de la parainfluenza canina vivo atenuado, tipo 2, cepa cpiv-2-bio 15, virus rabia inactivado, cepa sad vnukovo-32, leptospira interrogans inactivada, serogrupo icterohaemorrgagiae serovar icterohaemorrhagiae, cepa mslb 1089, leptospira interrogans inactivada, serogrupo canicola servorar canicola, cepa mslb 1090, leptospira kirschneri inactivada, serogrupo grippotyphosa serovar grippotyphosa, cepa mslb 1091, leptospira interrogans inactivada, serogrupo australis serovar bratislava, cepa mslb 1088 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: hidroxido de aluminio, edetico acido, trometamol, sacarosa, dextrano 70, agua para preparaciones inyectables, cloruro de sodio, cloruro potasico, dihidrogenofosfato de potasio, hidrogenofosfato de sodio dodecahidrato - vacunas bacterianas y víricas vivas e inactivadas - perros

Spanje - Spaans - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

zoetis belgium sa - virus de la parainfluenza canina vivo atenuado, tipo 2, cepa cpiv-2-bio 15, virus rabia inactivado, cepa sad vnukovo-32, leptospira interrogans inactivada, serogrupo icterohaemorrgagiae serovar icterohaemorrhagiae, cepa mslb 1089, leptospira interrogans inactivada, serogrupo canicola servorar canicola, cepa mslb 1090, leptospira kirschneri inactivada, serogrupo grippotyphosa serovar grippotyphosa, cepa mslb 1091, leptospira interrogans inactivada, serogrupo australis serovar bratislava, cepa mslb 1088 - liofilizado y disolvente para suspensiÓn inyectable - excipientes: hidroxido de aluminio, edetico acido, trometamol, sacarosa, dextrano 70, agua para preparaciones inyectables, cloruro de sodio, cloruro potasico, dihidrogenofosfato de potasio, hidrogenofosfato de sodio dodecahidrato - vacunas bacterianas y víricas vivas e inactivadas - perros

Europese Unie - Spaans - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Europese Unie - Spaans - EMA (European Medicines Agency)

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. los inicios de inmunidad se han demostrado 1 semana después del ciclo de vacunación primaria para componentes de rinotraqueitis, calicivirus y chlamydophila felis.. la duración de la inmunidad es de 1 año después de la última (re) vacunación.

Europese Unie - Spaans - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Spaans - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals para felidae, - gatos - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. se han demostrado los inicios de inmunidad una semana después del ciclo de vacunación primaria para componentes de rinotraqueitis, calicivirus, chlamydophila felis y panleucopenia. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Spaans - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals para felidae, - gatos - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europese Unie - Spaans - EMA (European Medicines Agency)

virbac s.a. - virus de la rabia vivo atenuado, cepa sag2 - las vacunas virales - raccoon dogs (nyctereutes procyonoides); red foxes (vulpes vulpes) - para la inmunización activa de zorros rojos y perros mapaches para prevenir la infección por el virus de la rabia. la duración de la protección es de al menos 6 meses.

Spanje - Spaans - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

virbac - leptospira interrogans, serovariedad canicola, inactivada, cepa 601903 - suspensiÓn inyectable - leptospira interrogans, serovariedad canicola, inactivada, cepa 601903 4350 - leptospira - perros

Europese Unie - Spaans - EMA (European Medicines Agency)

ceva santé animale - virus atenuado de vacuna viva contra la rabia, cepa spbn gasgas - immunologicals para los miembros de la familia canidae, las vacunas virales - red foxes (vulpes vulpes); raccoon dogs (nyctereutes procyonoides) - para la inmunización activa de zorros y perros mapaches contra la rabia para prevenir la infección y la mortalidad.